ANSELL News & Analysis

In a week of strong earnings from health giants CSL and Cochlear, this healthcare business reported limp revenue and sales numbers but there is...

Two health stocks and an Australian property group were among the notable ASX purchases made by fund managers in recent months.

It may rank as one of Morningstar’s most overvalued sectors, but the safety of healthcare stocks can still provide value to investors—if...

We maintain our view current margin pressures are mostly temporary and leave our long-term estimates broadly unchanged.

The corona sell-off has unearthed discounts among makers of gloves, pharmaceutical goods and spray-on skin technology.

Global industrial and medical glove maker Ansell is trading higher after raising its earnings guidance and posting a slight rise in first-half profit.

A tripling of profits at Ansell was shaded by US tariff-linked cost uncertainties, while Primary Healthcare posted a positive $8.9m result after...